Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by David Kunkel
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- David Kunkel
Associate Clinical Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 35 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Vanda Pharmaceuticals
- Links
- Study Website
- ID
- NCT04028492
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 201 study participants
- Last Updated